Investigational Extravascular ICD System

Investigational Extravascular ICD System

Medtronic Begins Pilot Study of Investigational Extravascular ICD System   Chronic Study Evaluating New Extravascular ICD System Designed to Deliver Pacing and Defibrillation Therapy Via a Lead Placed Under the Sternum, Outside the Heart and Veins Medtronic plc (NYSE:MDT) today announced the start of a pilot study of its investigational Extravascular ICD Implantable Cardioverter Defibrillator […]

HeartLogic devices

HeartLogic Diagnostic tool may reduce further hospitalisations

Please note this is a press release from Boston Scientific Europe talking about their new innovation HeartLogic Boston Scientific Launches the HeartLogic™* Heart Failure Diagnostic in Europe The HeartLogic Diagnostic is the first and only heart failure diagnostic tool proven to detect 70% of heart failure events several weeks in advance, potentially reducing further hospitalisation […]

Living with Heart Failure Infographic - Slide 1

Living With Heart Failure Infographic #HFpatientsTellUs

Our Heart Failure Community Share the Impact of Heart Failure, Their Self Care Priorities, How They Feel, and What They Want from Future Medical Therapy, with our New Living with Heart Failure Infographic. We asked our heart failure community how they feel about heart failure, in a 5-minute poll, enabling insight and opening the door […]

Heart Failure Infographic

Heart Failure Infographic

Heart Failure Infographic makes Heart Failure clearer for everyone Heart failure is a syndrome caused by many different reasons. We have produced this heart failure infographic to help people understand – What it is What are the common symptoms of heart failure What are the common causes of heart failure Some facts and figures around […]

NIQOR National Heart Failure Audit

More Patients than Ever Surviving Heart Failure, National Audit Finds

More patients than ever surviving heart failure following key improvements, audit finds Acute heart failure necessitating hospital admission is a life threatening condition. The quality of care including specialist involvement during an admission, determines the immediate and long-term outcomes including likelihood of survival. Yet while the audit reports several improvements, it also found that the […]

Marketing Authorisation Granted for Veltessa® (Patiromer) To Treat Patients With Hyperkalaemia

Marketing Authorisation Granted for Veltessa® (Patiromer) To Treat Hyperkalaemia

VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AND VIFOR PHARMA UK TODAY ANNOUNCED THAT THE EUROPEAN COMMISSION (EC) HAS GRANTED MARKETING AUTHORISATION OF VELTASSA® (PATIROMER) FOR THE TREATMENT OF ELEVATED SERUM POTASSIUM LEVELS (HYPERKALAEMIA) IN ADULTS Patiromer is a sodium-free potassium binder licensed for the treatment of hyperkalaemia in adult patients. Hyperkalaemia is a potentially life-threatening […]

1 2 3 19